From Crisis 459% Gain: Intel's Bold Turnaround Now
Intel overcame a tough 12 months to deliver a striking rebound. Analysts say the AI-led strategy and foundry expansio...
Stock picking may pay off in certain market conditions and for investors with time and expertise. Learn factors to consider before deviating from index funds.
26,454 articlesIntel overcame a tough 12 months to deliver a striking rebound. Analysts say the AI-led strategy and foundry expansio...
Cerebras' first earnings report brings a clear message for AI stock shoppers: growth alone isn't enough. Here's how t...
Nebius’s stock surges latest after the company lands a Meta partnership valued at up to $27 billion, building on a re...
Lululemon faces a pivotal moment after its latest earnings. This analysis breaks down what's working, what's slowing,...
Netflix trades near its 52-week low as operating strength clashes with subscriber-growth concerns. A stronger FY26 ca...
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Lululemon posted a mixed quarter: international sales led growth while the core US market softened. This analysis dig...
A warning from SK Hynix could ripple through the NAND market and Sandisk stock. This guide breaks down what the hynix...
A clear, practical guide to reading a 2026 earnings transcript. Learn which numbers matter, how management commentary...
An AI-chip IPO like Cerebras can spark excitement and risk in one breath. cerebras opened $350 nearly, blasting past ...
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
RadNet is entering 2026 with a mix of imaging volumes, payer dynamics, and technology investments. This guide breaks ...